Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 2.8600
- -0.0600-2.05%
Close Dec 3 16:00 ET
- 2.8600
- 0.00000.00%
Post 20:01 ET
3.02MMarket Cap-293P/E (TTM)
2.9300High2.7300Low24.90KVolume2.9300Open2.9200Pre Close70.43KTurnover2.37%Turnover RatioLossP/E (Static)1.06MShares10.350052wk High0.61P/B3.01MFloat Cap2.167852wk Low--Dividend TTM1.05MShs Float3118.4994Historical High--Div YieldTTM6.85%Amplitude2.1670Historical Low2.8280Avg Price1Lot Size
Phio Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 32.66%-1.95M | 35.87%-1.78M | 25.74%-2.01M | 11.38%-10.75M | 12.38%-2.37M | 17.75%-2.9M | -14.08%-2.77M | 21.94%-2.71M | -2.29%-12.13M | -9.47%-2.71M |
| Net income from continuing operations | 45.18%-1.52M | 27.58%-1.85M | 40.20%-2.15M | 5.70%-10.83M | 30.61%-1.9M | 22.26%-2.78M | -0.71%-2.55M | -36.34%-3.6M | 13.60%-11.48M | 20.86%-2.73M |
| Operating gains losses | --0 | --0 | --3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --0 | -97.87%1K | -27.66%34K | -4.66%184K | -6.52%43K | 2.17%47K | -4.08%47K | -9.62%47K | 0.52%193K | -66.42%46K |
| Change In working capital | -87.89%-481K | 114.60%53K | -89.95%74K | 57.32%-536K | -953.23%-653K | -158.59%-256K | -1,110.00%-363K | 169.11%736K | -226.87%-1.26M | -107.83%-62K |
| -Change in prepaid assets | 164.74%123K | 38.44%-221K | 46.18%459K | -2,550.00%-196K | -82.89%39K | -124.42%-190K | 21.96%-359K | 158.36%314K | -96.68%8K | -9.16%228K |
| -Change in payables and accrued expense | -1,787.50%-604K | 813.33%274K | -177.09%-350K | 82.00%-205K | -154.65%-657K | 96.21%-32K | -93.49%30K | 191.35%454K | -231.68%-1.14M | -146.07%-258K |
| -Change in other current liabilities | --0 | --0 | -9.38%-35K | -8.00%-135K | -9.38%-35K | -6.25%-34K | -9.68%-34K | -6.67%-32K | -7.76%-125K | -68.42%-32K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 32.66%-1.95M | 35.87%-1.78M | 25.74%-2.01M | 11.38%-10.75M | 12.38%-2.37M | 17.75%-2.9M | -14.08%-2.77M | 21.94%-2.71M | -2.29%-12.13M | -9.47%-2.71M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 95.87%-5K | 0 | 0 | -137.25%-121K | 0 | ||||
| Net PPE purchase and sale | --0 | ---- | ---- | 95.87%-5K | --0 | --0 | ---- | ---- | -137.25%-121K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | 95.87%-5K | --0 | --0 | ---- | ---- | -137.25%-121K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.65M | 0 | 89.47%-4K | 28,611.54%7.41M | 120,050.00%2.4M | 0 | 5.05M | -52.00%-38K | -100.12%-26K | 300.00%2K |
| Net common stock issuance | --2.65M | --0 | --0 | --7.44M | --2.4M | --0 | --5.05M | ---11K | --0 | --0 |
| Net preferred stock issuance | --0 | --0 | --0 | -200.00%-2K | --0 | --0 | --0 | ---2K | --2K | --2K |
| Net other financing activities | --0 | --0 | 84.00%-4K | 7.14%-26K | ---1K | --0 | --0 | 0.00%-25K | -2,700.00%-28K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --2.65M | --0 | 89.47%-4K | 28,611.54%7.41M | 120,050.00%2.4M | --0 | --5.05M | -52.00%-38K | -100.12%-26K | 300.00%2K |
| Net cash flow | ||||||||||
| Beginning cash position | -58.63%4.7M | -28.73%6.48M | -28.24%8.49M | -50.92%11.83M | -41.81%8.46M | -37.15%11.36M | -55.70%9.09M | -50.92%11.83M | 68.65%24.11M | -45.32%14.53M |
| Current changes in cash | 123.86%692K | -178.21%-1.78M | 26.62%-2.02M | 72.78%-3.34M | 101.22%33K | 17.99%-2.9M | 193.15%2.27M | 23.68%-2.75M | -225.10%-12.28M | -9.34%-2.7M |
| End cash Position | -36.27%5.39M | -58.63%4.7M | -28.73%6.48M | -28.24%8.49M | -28.24%8.49M | -41.81%8.46M | -37.15%11.36M | -55.70%9.09M | -50.92%11.83M | -50.92%11.83M |
| Free cash flow | 32.66%-1.95M | 35.99%-1.78M | 25.74%-2.01M | 12.21%-10.75M | 12.38%-2.37M | 17.92%-2.9M | -13.82%-2.78M | 24.21%-2.71M | -2.86%-12.25M | -9.47%-2.71M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.